Healthcare stocks

Our Q&As are emailed in our Saturday Morning Report, find the answer to this question below.

Ask a question

The Latest Q&A

Question asked 05/03/2021

Healthcare stocks

Hi I feel I am a little over weight with health stocks , I hold RMD , SHL , CSL and yet at the current price of RMD and CSL I feel I should be buying more any thoughts as to the best of these? Thanks Glenn .

Answer

Hi Glenn,

We’ve already mentioned a few times this week that we like CSL Ltd (CSL) around $240 hence today I’ve focused on ResMed (RMD).

Sleep dis-order company RMD has struggled over the last 6-months along with most growth stocks however short-term after correcting 20% we believe RMD has entered an accumulation area – note, in the bigger picture we are sticking with our outperformance by value over growth outlook through 2021 / 22.

So, short answer is MM likes RMD into weakness below $24 but we wouldn’t be going “all-in” as the current trend is clearly down.

chart

ResMed (RMD)

LAST UPDATED 05/03/2021 17:12

Latest Reports

Afternoon report 26/04/2024

The Match Out: ASX (nearly) gives up week’s gain in tough Friday session

The local market dropped ~100 points on the open, failing to see any reprieve following two weaker sessions out in the US since our close on Wednesday. After dropping back below 7600 the index traded in a reasonably tight 30-point range for the rest of the session, failing to join in on the rally across the region and what’s showing on the US Futures ahead of their Friday session. BHP managed to take 31pts off the market alone today, weakness coming after they lobbed an all scrip bid for Anglo American (AAL LN). Despite the soggy end to the week, the ASX200 finished marginally higher, +8pts / +0.11%.

Morning report 26/04/2024

What Matters Today: With rate hikes back on the table, are retail stocks too expensive?

The ASX consumer discretionary (retail) stocks have demonstrated their need for a strong bond market. In the short term, we remain concerned they’ve disconnected slightly from the influential credit markets. Futures markets are starting to price in the risk of rate hikes in 2024, with some well-respected economists becoming increasingly hawkish. Judo Bank’s Warren Hogan is calling for three hikes to 5.1%; previously, he was looking for cuts in 2025, but the recent hot inflation data has seen him reverse this outlook. We feel the call for rates to hit 5.1% in 2024 is too aggressive, but we cannot see Michele Bullock considering rate cuts until the inflation genie is firmly back in the bottle.